UroToday - Prostate Cancer

Home

Prostate Cancer

UroToday's Prostate Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of prostate cancer. Also available are conference coverage for all timely prostate cancer science, streaming media presentations, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind Regards,
Christopher P. Evans MD,
Associate Section Editor of Oncology/Prostate Cancer,
UroToday International Journal

Display

results per page

Results 1 - 30 of 5471

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Editorial - Laparoendoscopic single-site surgery: Initial hundred patients
Friday, 20 November 2009
BERKELEY, CA (UroToday.com) - This is the first report of a large number of patients who underwent laparoendoscopic single site surgery (LESS).
Login to read more...

Editorial - Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: Analysis of the SEARCH database
Friday, 20 November 2009
BERKELEY, CA (UroToday.com) - In the online edition of Urology, Dr. Steven Chang and associates from the SEARCH database report that time to first detectable ultrasensitive PSA (uPSA) identifies men with low-risk recurrence prostate cancer (CaP).
Login to read more...

PSA levels of 4.0 - 10 ng/mL and negative digital rectal examination. Antibiotic therapy versus immediate prostate biopsy - Abstract
Friday, 20 November 2009
Department of Urology, Tel Aviv Central Consulting Clinic, Clalit Healthcare Services, Tel Aviv, Israel.
read more

Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study - Abstract
Friday, 20 November 2009
Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School; Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston MA.
read more

An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy - Abstract
Friday, 20 November 2009
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA.
read more

Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft - Abstract
Friday, 20 November 2009
The Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University In Vivo Cellular and Molecular Imaging Center Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
read more

A prospective study of lifetime physical activity and prostate cancer incidence and mortality - Abstract
Friday, 20 November 2009
Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
read more

Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer - Abstract
Friday, 20 November 2009
Department of Urology, Indiana University Medical Center, Indianapolis, IN, USA.
read more

Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience - Abstract
Friday, 20 November 2009
Department of Urology, Tokai University Hachioji Hospital, Hachioji, Tokyo, Japan.
read more

Penile shortening after radical prostatectomy and Peyronie's surgery - Abstract
Friday, 20 November 2009
Urology Specialists, SC, Rush University Medical Center, 1725 W. Harrison Street, Suite 352, Chicago, IL 60612, USA.
read more

The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment - Abstract
Friday, 20 November 2009
Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
read more

The significance of a positive bladder neck margin after radical prostatectomy: The American Joint Committee on Cancer pathological stage T4 designation is not warranted - Abstract
Friday, 20 November 2009
James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland
read more

Editorial - Comparative effectiveness of minimally invasive vs open radical prostatectomy
Thursday, 19 November 2009
BERKELEY, CA (UroToday.com) - Minimally invasive radical prostatectomy (MIRP) for prostate cancer (CaP) is the most common treatment modality for localized CaP in the United States.
Login to read more...

Relationship between Day 0 dosimetric parameters and biochemical relapse-free survival in patients treated with transperineal permanent prostate interstitial brachytherapy with (125)I seeds - Abstract
Thursday, 19 November 2009
Department of Oncology, Radiation Oncology Division, Clínica Universitaria de Navarra, Navarre, Spain.
read more

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design - Abstract
Thursday, 19 November 2009
Associate Clinical Investigator, Laboratory of Tumor Immunology and Biology,Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA.
read more

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence - Abstract
Thursday, 19 November 2009
Harvard Radiation Oncology Program, Harvard Medical School; Departments of Pathology, Radiation Oncology, Medical Oncology, and Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA.
read more

Prostatic specific antigen for prostate cancer detection - Abstract
Thursday, 19 November 2009
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065 , USA.
read more

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review - Abstract
Thursday, 19 November 2009
Department of Social Medicine, University of Bristol, Bristol, United Kingdom.
read more

Dietary patterns and prostate cancer risk - Abstract
Thursday, 19 November 2009
Cancer Epidemiology Centre, The Cancer Council of Victoria and Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia.
read more

Editorial - XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors
Wednesday, 18 November 2009
BERKELEY, CA (UroToday.com) - In the September 22, 2009 issue of the Proceedings of the National Academy of Sciences, Dr. Robert Schlaberg and colleagues verify that the DNA and protein from the xenotropic murine leukemia virus-related virus (XMRV) exists in prostate cancer (CaP) tissue.
Login to read more...

Palliative systemic therapy of castration-resistant prostate cancer : Current developments - Abstract
Wednesday, 18 November 2009
Urologische Universitätsklinik, Prittwitzstrasse 43, 89075, Ulm, Deutschland.
read more

High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer - Abstract
Wednesday, 18 November 2009
Department of Radiation Oncology, The William Buckland Radiotherapy Centre, Alfred Hospital, Melbourne, Victoria, Australia.
read more

Morphologic characterization of preoperatively treated prostate cancer: Toward a post-therapy histologic classification - Abstract
Wednesday, 18 November 2009
University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
read more

Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis - Abstract
Wednesday, 18 November 2009
Kanazawa University Hospital Cancer Center, Kanazawa, Japan.
read more

YouTube as source of prostate cancer information - Abstract
Wednesday, 18 November 2009
Section of Urology, Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
read more

Beyond the Abstract - DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme, by Sumit Isharwal, MD, et al.
Tuesday, 17 November 2009
BERKELEY, CA (UroToday.com) - The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Login to read more...

Folate intake and prostate cancer risk: a case-control study - Abstract
Tuesday, 17 November 2009
Oregon Health & Science University and Portland Veterans Affairs Medical Center, Portland, Oregon 97239-3098, USA.
read more

Radical prostatectomy reigns supreme - Abstract
Tuesday, 17 November 2009
Division of Urologic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
read more

Radical prostatectomy for high-risk prostate cancer - Abstract
Tuesday, 17 November 2009
Department of Urology, Mayo Clinic, Rochester, MN, USA.
read more

Patient decision aids for prostate cancer treatment: A systematic review of the literature - Abstract
Tuesday, 17 November 2009
Division of General Internal Medicine, University of California at San Francisco, 400 Parnassus Avenue, 4th Floor, Box 0320, San Francisco, CA 94143-0320, USA.
read more

Focus on Prostate Cancer

Focus on Prostate Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.






Technology Centers Prostate Cancer - Prognostic Nomograms - by Ricardo Sanchez-Ortiz, MD EAU Position Statement on Screening for Prostate Cancer - News Release Anxiety and distress during active surveillance for early prostate cancer - by Roderick C.N. van den Bergh, MD, et al. Degarelix: A new approach for the treatment of prostate cancer - by Bo-Eric Persson, MD A 64-year-old man with low-risk prostate cancer: Review of prostate cancer treatment - by Sandip M. Prasad, MD and Martin G. Sanda, MD - Editor's Pick Apocrine Sweat Gland Obstruction by Antiperspirants Allowing Transdermal Absorption of Cutaneous Generated Hormones and Pheromones as a Link to the Observed Incidence Rates of Breast and Prostate Cancer in the 20th Century - by Kris G. McGrath, MD A Novel Communication Role for CYP17A1 in the Progression of Castration-Resistant Prostate Cancer - by Emma Tomlinson Guns, PhD Phase I/II Trial of Docetaxel and Concurrent Radiation Therapy in Localized High Risk Prostate Cancer (AGUSG 03-10) - by Michael Perrotti, MD, et al. A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America - by Marc Gittelman, MD - Editor's Pick Management of the Side Effects of Androgen Deprivation Therapy in Men with Prostate Cancer - by Thomas W Flaig, MD Sexually Transmissible Infections and Prostate Cancer Risk - by Wen-Yi Huang, PhD, MSPH, et al. Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey - by Gary G. Schwartz, PhD, MPH - Editor's Pick Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 - by Christopher P. Evans, MD, FACS Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: Description of the technique and continence outcomes - by Christopher P. Evans, MD, FACS Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings - by Christopher P. Evans, MD, FACS High-Dose-Rate Brachytherapy for Localized Prostate Adenocarcinoma Post Abdominoperineal Resection of the Rectum and Pelvic Irradiation: Technique and Experience - by Christopher P. Evans, MD, FACS Impact of Surgeon and Hospital Volume on Outcomes of Radical Prostatectomy - by Christopher P. Evans, MD, FACS PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- And High-Grade (Gleason Score 6 and 7) Cancer - by Christopher P. Evans, MD, FACS A Broader Role for 5ARIs in Prostate Disease? Existing Evidence and Emerging Benefits - by Christopher P. Evans, MD, FACS Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study - by Christopher P. Evans, MD, FACS - Editor's Pick Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3 - by Christopher P. Evans, MD, FACS HIV and Prostate Cancer: A Systematic Review of the Literature - by Christopher P. Evans, MD, FACS - Editor's Pick Obesity-Related Plasma Hemodilution and PSA Concentration among Men with Prostate Cancer - by Christopher P. Evans, MD, FACS - Editor's Pick Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality - by Christopher P. Evans, MD, FACS Editor's Pick Patient Response to Total Intravenous Sedation (TIVS) for Outpatient Ultrasound-Guided Prostate Biopsy - by Ahmed Al-Sameraaii, MD, et al. A Four-Gene Expression Signature for Prostate Cancer Cells Consisting of UAP1, PDLIM5, IMPDH2, and HSPD1 - by Herbert A. Fritsche, PhD, et al. Peripheral Zone Sonographic Changes of the Prostate - by El-Housseiny Ismail Ibrahiem (El- Zalouey), MD, et al. Successful Early Prostate Cancer Screening by Three-Dimensional Color Doppler Imaging-Transrectal Ultrasound: A Prospective Study - by Walter Merkle, MD Mechanism of Neuroendocrine Differentiation in Prostate Cancer: BMP6-Macrophage-IL6 Loop via Obligatory Involvement of Both Smad-Dependent and -Independent Pathway - by Isaac Yi Kim, MD, et al. Secondary Therapy In Localized Prostate Cancer: Results From The Prostate Cancer Outcomes Study - by David F. Penson, MD, et al. Prostate Cancer Diagnosis in High Risk Patients The Finasteride Challenge Trial - by Bernd J Schmitz-Dräger, MD, et al. Key targets of hormonal treatment of prostate cancer. Part 2: The androgen receptor and 5α-reductase Robotic-assisted radical prostatectomy: A review of current outcomes Locally advanced prostate cancer: the role of surgical management Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways Prostate Cancer: A Serious Disease Suitable for Prevention Prostate-Specific Antigen Kinetics in Localized and Advanced Prostate Cancer
SIU Satellite Symposium 2007 Advanced Prostate Cancer: Current Status, Controversies, and Future Directions By Fred Saad, MD, FRCS Bone Metastases Module By Edward Chow MBBS, PhD, FRCPC Accompanying Case Studies A 64 year old retired pharmacist presents to his primary care physician with complaints of urinary urgency and frequency of 6 months duration and of increasingly severe low back and right hip pain of 3 months duration. A 73 year old retired commericial fisherman was diagnosed 3 years ago with a Stage IV [Gleason 3 + 3(6)] prostate cancer with bone being the only site of metastases. A 55 year old woman presents to her primary care physician with occasional gross painless hematuria for 4 months. A 59 year old male had a diagnosis of renal cell carcinoma of the left kidney made 2 years ago after presenting with flank pain and hematuria.
9th International Prostate Forum - View Session Highlights Evaluation of the prostate cancer prevention trial risk calculator in a high-risk screening population - Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting What to do when the pathologist reports "positive margins" - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting Open prostatectomy is best - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting One year result of the retrourethral transobturator sling for the minimal-invasive treatment of male stress incontinence after radical prostatectomy - Slide Presentation by Christian G. Stief, MD at the Urological Research Society (URS) 25th Annual Meeting Prostate cancer detection using a novel computerized three-dimensional prostate biopsy template (Targetscan™): Results of a multicenter prospective data registry - Slide Presentation - Slide Presentation by Samir S. Taneja, MD at the Urological Research Society (URS) 25th Annual Meeting VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Session Highlights VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Slide Presentations American Society of Clinical Oncology (ASCO) 2009 Annual Meeting - View Prostate Cancer Session Highlights American Urological Association (AUA) 2009 Annual Meeting - View Prostate Cancer Session Highlights Post Prostatectomy Incontinence Study - SUFU 2009 - Highlight of a Presentation by Victor W. Nitti, MD Open, Laparoscopic and Robotic Prostatectomy: Much Ado About Nothing? - WUF 2009 - Lecture Presented by Christopher P. Evans, MD, FACS Society of Urologic Oncology (SUO) 9th Annual Winter Meeting - View Prostate Cancer Session Highlights Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Advances in the Treatment of Hormone Refractory Prostate Cancer - Masters in Urology 2008 - Session Highlight The American Society for Therapeutic Radiology and Oncology - 50th Annual Meeting - ASTRO 2008 - Prostate Cancer Abstracts American Society of Clinical Oncology - 44th Annual Meeting - ASCO 2008 - Prostate Cancer Abstracts The American Urological Association 2008 Annual Meeting - AUA 2008 Prostate Cancer Session Highlights Engineering and Urology Society - 23rd Annual Meeting - EUS 2008 - Prostate Cancer Abstracts